Effect of Full-House ESS With Nasopharyngeal Lymphoid Tissue Ablation on Nasal Polyps

ConditionNasal Polyps
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorTongji Hospital

About this trial

This study is designed to evaluate whether the addition of nasopharyngeal lymphoid tissue ablation to full-house endoscopic sinus surgery (ESS) provides superior control of nasal mucosa inflammation compared to full-house ESS alone in patients with nasal polyps. Thirty-two adult participants will be randomly assigned to undergo either full-house ESS only or full-house ESS combined with nasopharyngeal lymphoid tissue ablation. The primary outcome will be assessed through changes in inflammatory cell profiles at 1, 3, and 6 months postoperatively. Secondary outcomes include inflammatory cytokine levels, symptom scores, endoscopic findings, polyp recurrence rates, and safety measures.

Eligibility criteria

Qualifiers

Aged 18-65 years

Diagnosed with CRSwNP according to EPOS criteria

Blood eosinophil count > 0.3 × 10⁹/L

Disqualifiers

Pregnant or lactating women.

Cystic fibrosis

primary ciliary dyskinesia

fungal ball rhinosinusitis

Trial design

Treatments tested in this trial

  • Nasopharyngeal Lymphoid Tissue Ablation
  • Full-House Endoscopic Sinus Surgery

Treatment groups

32 Participants
are divided into 2 treatment groups

Sponsors and collaborators